Theratechnologies Inc.THTXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank67
3Y CAGR-27.5%
5Y CAGR-4.8%
Year-over-Year Change
Research and development spending
3Y CAGR
-27.5%/yr
vs +47.6%/yr prior
5Y CAGR
-4.8%/yr
Recent deceleration
Acceleration
-75.1pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $14.08M | -17.1% |
| 2024 | $16.97M | -44.1% |
| 2023 | $30.37M | -17.8% |
| 2022 | $36.94M | +30.6% |
| 2021 | $28.27M | +56.9% |
| 2020 | $18.02M | +66.2% |
| 2019 | $10.84M | +39.4% |
| 2018 | $7.78M | -15.6% |
| 2017 | $9.21M | +78.0% |
| 2016 | $5.18M | - |